HARVARD BIOSCIENCE INC Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Harvard Bioscience Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Harvard Bioscience Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$2.62M, a 805% decline year-over-year.
  • Harvard Bioscience Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$7.42M, a 112% decline year-over-year.
  • Harvard Bioscience Inc annual Nonoperating Income (Expense) for 2023 was -$4.45M, a 98.1% decline from 2022.
  • Harvard Bioscience Inc annual Nonoperating Income (Expense) for 2022 was -$2.25M, a 1.81% decline from 2021.
  • Harvard Bioscience Inc annual Nonoperating Income (Expense) for 2021 was -$2.21M, a 70.6% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$7.42M -$2.62M -$2.99M -805% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$4.43M -$1.21M +$1.68M +58.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$6.11M -$2.21M -$1.66M -307% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$4.45M -$1.39M -$950K -218% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$3.5M $371K +$1.3M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$4.8M -$2.89M -$2.32M -402% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$2.48M -$542K -$236K -77.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$2.25M -$435K +$133K +23.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$2.38M -$928K -$425K -84.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$1.95M -$577K +$113K +16.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$2.07M -$306K +$139K +31.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q4 2021 -$2.21M -$568K +$2.74M +82.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$4.94M -$503K +$1.09M +68.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$6.04M -$690K +$734K +51.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$6.77M -$445K +$743K +62.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$7.51M -$3.3M -$1.77M -115% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$5.74M -$1.6M -$288K -22% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$5.46M -$1.42M -$64K -4.71% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$5.39M -$1.19M +$486K +29% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$5.88M -$1.54M +$162K +9.55% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$6.04M -$1.31M +$489K +27.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$6.53M -$1.36M +$125K +8.42% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$6.65M -$1.67M +$2.31M +57.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$8.96M -$1.7M -$848K -99.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$8.11M -$1.8M -$1.52M -556% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$6.59M -$1.49M -$1.02M -221% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$5.57M -$3.98M -$3.58M -895% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$1.99M -$849K -$984K -729% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$1M -$274K -$207K -309% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$795K -$463K -$536K -734% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$259K -$400K -$178K -80.2% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$81K $135K +$569K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$650K -$67K +$254K +79.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$904K $73K +$599K Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$1.5M -$222K +$392K +63.8% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$1.9M -$434K +$515K +54.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 -$2.41M -$321K +$148K +31.6% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-17
Q2 2015 -$2.56M -$526K -$58K -12.4% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-17
Q1 2015 -$2.5M -$614K -$299K -94.9% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-17
Q4 2014 -$2.2M -$949K -$630K -197% Oct 1, 2014 Dec 31, 2014 10-K 2016-04-29
Q3 2014 -$1.57M -$469K -$111K -31% Jul 1, 2014 Sep 30, 2014 10-K 2016-04-29
Q2 2014 -$1.46M -$468K -$138K -41.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-04-29
Q1 2014 -$1.32M -$315K -$220K -232% Jan 1, 2014 Mar 31, 2014 10-K 2016-04-29
Q4 2013 -$1.1M -$319K -$170K -114% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 -$932K -$358K -$180K -101% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 -$752K -$330K -$104K -46% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 -$648K -$95K +$290K +75.3% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
Q4 2012 -$938K -$149K +$254K +63% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$1.19M -$178K +$160K +47.3% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$1.35M -$226K +$293K +56.5% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$1.65M -$385K -$110K -40% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 -$1.54M -$403K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$338K +$42K +11.1% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 -$519K -$644K -515% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 -$275K Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q3 2010 -$380K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $125K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.